Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 7:30 pm Purchase | 2021-12-31 | 13G | Statera Biopharma, Inc. STAB | HARPEL JAMES W | 1,126,956 3.510% | 1,126,956 (New Position) | Filing History |
| 2022-02-14 5:24 pm Sale | 2021-12-31 | 13G | Intrusion Inc. INTZ | HARPEL JAMES W | 33,150 3.530% | -16,859 (-33.71%) | Filing History |
| 2021-02-11 1:42 pm Purchase | 2020-12-31 | 13G | Cytocom, Inc. CBLI | HARPEL JAMES W | 1,205,979 9.000% | 432,048 (+55.83%) | Filing History |
| 2021-02-11 1:14 pm Purchase | 2020-12-31 | 13G | Intrusion Inc. INTZ | HARPEL JAMES W | 50,009 5.750% | 13,134 (+35.62%) | Filing History |
| 2020-01-27 10:00 am Purchase | 2019-06-10 | 13G | Intrusion Inc. INTZ | HARPEL JAMES W | 36,875 5.400% | 36,875 (New Position) | Filing History |
| 2020-01-24 4:51 pm Purchase | 2019-05-14 | 13G | Cytocom, Inc. CBLI | HARPEL JAMES W | 773,931 6.800% | 773,931 (New Position) | Filing History |